Strata Skin Sciences (NASDAQ: SSKN) furnishes December 2025 investor deck

Rhea-AI Filing Summary

Strata Skin Sciences, Inc. furnished a new investor presentation, dated December 2025, for investors and analysts. The company posted this presentation on its website and attached it as Exhibit 99.1 to a current report. The material is provided under a section that means it is being furnished, not filed, so it is not subject to certain liability provisions and will only be incorporated into other documents if specifically referenced.

false0001051514NASDAQ00010515142025-12-162025-12-16

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): December 16, 2025

STRATA SKIN SCIENCES, INC.

(Exact Name of Registrant Specified in Charter)

Delaware	000-51481	13-3986004
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

5 Walnut Grove Drive, Suite 140, Horsham, Pennsylvania		19044
(Address of Principal Executive Offices)		(Zip Code)

Registrant's telephone number, including area code:  215-619-3200

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	SSKN	The NASDAQ Stock Market LLC

Item 7.01. Regulation FD Disclosure.

On December 16, 2025, STRATA Skin Sciences, Inc. (the “Company”) posted an investor presentation to its website at https://strataskinsciencesinc.gcs-web.com/. A copy of the investor presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information set forth in this item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

The following presentation is furnished as an exhibit to this Current Report on Form 8-K and shall not be deemed to be “filed”:

Exhibit No.	Exhibit Description
99.1	Investor Presentation dated December 2025, issued by Strata Skin Sciences, Inc.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	STRATA SKIN SCIENCES, INC.
Date: December 17, 2025	By:	/s/ John Gillings
		John Gillings
		Chief Accounting Officer

FAQ

What did Strata Skin Sciences (SSKN) disclose in this current report?

Strata Skin Sciences disclosed that it has posted a new investor presentation to its website and furnished the same presentation as Exhibit 99.1 to a current report.

Where can investors find the new Strata Skin Sciences investor presentation?

Investors can access the presentation on the company’s website at https://strataskinsciencesinc.gcs-web.com/, and it is also attached as Exhibit 99.1 to the report.

How is the Strata Skin Sciences investor presentation treated for SEC purposes?

The information in the investor presentation and the related item is being furnished and not deemed filed, meaning it is not subject to certain liabilities under Section 18 of the Securities Exchange Act.

What exhibits are included with the Strata Skin Sciences December 2025 report?

The report includes Exhibit 99.1, an investor presentation dated December 2025, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.

Who signed the Strata Skin Sciences December 2025 current report?

The report was signed on behalf of Strata Skin Sciences, Inc. by John Gillings, the company’s Chief Accounting Officer.

Does this Strata Skin Sciences filing include detailed financial results?

The report describes the furnishing of an investor presentation. Any detailed financial information would be contained within that presentation rather than in the body of the report itself.